Structural biology and high resolution studies of P-glycoprotein
Structural biology and high resolution studies of P-glycoprotein
批准号:
8536320
负责人:
GEOFFREY A CHANG
金额:
$28.47万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-20 至 2015-08-31
关键词:
ATP HydrolysisATP-Binding Cassette TransportersAnthracyclinesArchitectureBindingBuffaloesCamelsClinicCollaborationsCoupledCrystallizationDetergentsDevelopmentDiseaseDoxorubicinDrug DesignDrug TransportEngineeringFaceFutureGoalsHIVHumanLysineMalignant NeoplasmsMapsMembraneMembrane ProteinsMethodsMethylationModelingMolecularMolecular ConformationMulti-Drug ResistanceMusMutateNucleotidesP-GlycoproteinPharmaceutical PreparationsPharmacologic SubstancePlayResolutionRhodamineRoleSequence AlignmentSideStructureSurfaceTechniquesanalogbasedrug efficacyimprovedinhibitor/antagonistinterestnanobodiesnovelpublic health relevancestructural biology
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): The recent x-ray structure of mouse P-glycoprotein (Pgp) determined to 3.8 angstrom established the overall structural architecture of one of the most studied mammalian multidrug resistance (MDR) transporters. The structure of Pgp, however, is only a starting point for understanding its transport mechanism and potential inhibition. Clearly a higher resolution structure along with different conformations and co-crystal structures will be required to understand the detailed mechanism of transport coupled to ATP hydrolysis paving the way towards future rational drug design. We propose to (1) extend the resolution of Pgp crystals using very new membrane protein crystallization techniques and novel detergents to greatly improve the precision of the model, (2) determine additional conformations of Pgp both in the inward- and outward- facing conformations to map out the structural trajectories of the transport cycle, (3) determine the co-crystal structures of Pgp of two classical and clinically important compounds, doxorubicin and rhodamine, to understand poly-specific substrate binding, and (4) determine the x-ray structure of human Pgp or humanized version of Pgp, which will be very useful for drug design in the future.
PUBLIC HEALTH RELEVANCE: P-glycoprotein plays a significant role in drug efficacy and multidrug resistance to several diseases, including cancer and HIV. This high-impact project will provide a detailed molecular structural basis underlying its transport mechanism. The structures of Pgp should greatly facilitate the development of new drugs to circumvent multidrug resistance in the future.
期刊论文(12)
专著(0)
科研奖励(0)
会议论文
登录
查看更多内容
DOI:
10.1016/j.bmc.2012.05.075
发表时间:
2012-07-15
期刊:
BIOORGANIC & MEDICINAL CHEMISTRY
影响因子:
3.5
作者:
[Orchard, Alexandra, Schamerhorn, Gregory A., Calitree, Brandon D., Sawada, Geri A., Loo, Tip W., Bartlett, M. Claire, Clarke, David M., Detty, Michael R.]
通讯作者:
Detty, Michael R.
DOI:
10.1021/om500346j
发表时间:
2014-05-27
期刊:
Organometallics
影响因子:
2.8
作者:
[Kryman MW, Schamerhorn GA, Hill JE, Calitree BD, Davies KS, Linder MK, Ohulchanskyy TY, Detty MR]
通讯作者:
Detty MR
Snapshots of ligand entry, malleable binding and induced helical movement in P-glycoprotein.
配体进入,可延展结合和诱导螺旋蛋白的螺旋运动的快照。
DOI:
10.1107/s1399004715000978
发表时间:
2015-03
期刊:
Acta crystallographica. Section D, Biological crystallography
影响因子:
--
作者:
[Szewczyk P, Tao H, McGrath AP, Villaluz M, Rees SD, Lee SC, Doshi R, Urbatsch IL, Zhang Q, Chang G]
通讯作者:
Chang G
DOI:
10.1021/jm3004398
发表时间:
2012-05
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Sean P. Ebert;Bryan R Wetzel;Robert L. Myette;G. Conseil;S. Cole;G. Sawada;T. Loo;M. Bartlett;D. Clarke;M. Detty]
通讯作者:
Sean P. Ebert;Bryan R Wetzel;Robert L. Myette;G. Conseil;S. Cole;G. Sawada;T. Loo;M. Bartlett;D. Clarke;M. Detty
Selenorhodamine photosensitizers for photodynamic therapy of P-glycoprotein-expressing cancer cells.
DOI:
10.1021/jm501259v
发表时间:
2014-10-23
期刊:
Journal of medicinal chemistry
影响因子:
7.3
作者:
[Hill JE, Linder MK, Davies KS, Sawada GA, Morgan J, Ohulchanskyy TY, Detty MR]
通讯作者:
Detty MR
共 9 条
Biosynthesis of marine terpenoid natural products
-
批准号:10737210
-
项目类别:
-
资助金额:$50.4万
-
财政年份:2023
-
负责人:GEOFFREY A CHANG
-
依托单位:
Synthetically-evolved and engineered Nanobodies selective for Cb isoforms of PKA
-
批准号:10525796
-
项目类别:
-
资助金额:$43.45万
-
财政年份:2022
-
负责人:GEOFFREY A CHANG
-
依托单位:
Nanobody inhibitors of proton-sensing G protein-coupled receptors
-
批准号:10216432
-
项目类别:
-
资助金额:$15.78万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10380036
-
项目类别:
-
资助金额:$78.24万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10184466
-
项目类别:
-
资助金额:$75.92万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
Development of low-cost, field-ready nanobodies against snake venom
-
批准号:10255596
-
项目类别:
-
资助金额:$25.59万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
TDP-43 acetylation, phase separation, aggregation, and clearance by antibody-mediated degradation
-
批准号:10594973
-
项目类别:
-
资助金额:$75.99万
-
财政年份:2021
-
负责人:GEOFFREY A CHANG
-
依托单位:
Down syndrome, early cataracts, eye diseases, and beta-amyloid conformers
-
批准号:9893680
-
项目类别:
-
资助金额:$23.63万
-
财政年份:2019
-
负责人:GEOFFREY A CHANG
-
依托单位:
Down syndrome, early cataracts, eye diseases, and beta-amyloid conformers
-
批准号:10018872
-
项目类别:
-
资助金额:$19.7万
-
财政年份:2019
-
负责人:GEOFFREY A CHANG
-
依托单位:
Identity, mechanisms and early life impacts of transporter interfering compounds
-
批准号:10179393
-
项目类别:
-
资助金额:$55.86万
-
财政年份:2018
-
负责人:GEOFFREY A CHANG
-
依托单位:
Identity, mechanisms and early life impacts of transporter interfering compounds
-
批准号:10424481
-
项目类别:
-
资助金额:$53.94万
-
财政年份:2018
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure-based optimization of a novel pharmacological chaperone therapy for MPSIIIC
-
批准号:9343249
-
项目类别:
-
资助金额:$22.49万
-
财政年份:2017
-
负责人:GEOFFREY A CHANG
-
依托单位:
Targeting the mitochondrial pyruvate carrier to treat neurodegenerative disease
-
批准号:9262289
-
项目类别:
-
资助金额:$58.41万
-
财政年份:2014
-
负责人:GEOFFREY A CHANG
-
依托单位:
Targeting the mitochondrial pyruvate carrier to treat neurodegenerative disease
-
批准号:8843561
-
项目类别:
-
资助金额:$58.41万
-
财政年份:2014
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8389520
-
项目类别:
-
资助金额:$17.47万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8707456
-
项目类别:
-
资助金额:$17.24万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:9115590
-
项目类别:
-
资助金额:$16.79万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
Structure and function of ABC transporters to understand persistence of global ma
-
批准号:8550059
-
项目类别:
-
资助金额:$17.43万
-
财政年份:2012
-
负责人:GEOFFREY A CHANG
-
依托单位:
GEOFF CHANG PRT-CRYSTALLOGRAPHY OF INTEGRAL MEMBRANE PROTEINS
-
批准号:8362052
-
项目类别:
-
资助金额:$0.36万
-
财政年份:2011
-
负责人:GEOFFREY A CHANG
-
依托单位:
Molecular Organization of the Organic Cation-Proton Exchanger, MATE1
-
批准号:8730620
-
项目类别:
-
资助金额:$47.6万
-
财政年份:2010
-
负责人:GEOFFREY A CHANG
-
依托单位:
海外基金